Septic Arthritis and Prosthetic Joint Infections in Older Adults

被引：58

作者：

Nair, Rajeshwari ^{[1
,2
]}

Schweizer, Marin L. ^{[1
,2
]}

Singh, Namrata ^{[1
,2
]}

机构：

[1] Univ Iowa, Carver Coll Med, Dept Internal Med, Newton Rd, Iowa City, IA 52242 USA

[2] Iowa City Vet Affairs Healthcare Syst, Ctr Comprehens Access & Delivery Res & Evaluat CA, 601 Highway 6 West, Iowa City, IA 52246 USA

来源：

INFECTIOUS DISEASE CLINICS OF NORTH AMERICA | 2017年 / 31卷 / 04期

关键词：

Prosthetic joint infection; Septic arthritis; Biofilm; Older adult; SUPPRESSIVE ANTIBIOTIC-THERAPY; RISK-FACTORS; RHEUMATOID-ARTHRITIS; CLINICAL-FEATURES; NATIVE JOINTS; ARTHROPLASTY; HIP; KNEE; EPIDEMIOLOGY; COMPLICATIONS;

D O I：

10.1016/j.idc.2017.07.013

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

071005 [微生物学]; 100108 [医学免疫学];

摘要：

Older adults are at increased risk for septic arthritis and prosthetic joint infections (PJIs), owing at least in part to comorbid conditions and frailty. An increasing number of older adults undergo total joint arthroplasty to improve their quality of life. Infections in older adults differ from younger populations by the causative organisms, a great proportion of which are staphylococcal infections. Targeting important modifiable and nonmodifiable risk factors may prevent or reduce the burden of joint infections in older adults. This article summarizes the epidemiology, pathogenesis, clinical manifestations, diagnosis, management, and prevention of septic arthritis and PJIs in older adults.

引用

收藏

页码：715 / +

页数：16

相关论文

共 66 条

[1]

Prevention of Periprosthetic Joint Infection: What Are the Effective Strategies? [J].

Alijanipour, Pouya ;

Heller, Snir ;

Parvizi, Javad .

JOURNAL OF KNEE SURGERY, 2014, 27 (04) :251-258

[2]

Anguita-Alonso Paloma, 2005, Expert Rev Anti Infect Ther, V3, P797, DOI 10.1586/14787210.3.5.797

[3]

Morbidity and Mortality in the Thirty-Day Period Following Total Hip Arthroplasty: Risk Factors and Incidence [J].

Belmont, Philip J., Jr. ;

Goodman, Gens P. ;

Hamilton, William ;

Waterman, Brian R. ;

Bader, Julia O. ;

Schoenfeld, Andrew J. .

JOURNAL OF ARTHROPLASTY, 2014, 29 (10) :2025-2030

[4]

Risk factors for prosthetic joint infection: Case-control study [J].

Berbari, EF ;

Hanssen, AD ;

Duffy, MC ;

Steckelberg, JM ;

Ilstrup, DM ;

Harmsen, WS ;

Osmon, DR .

CLINICAL INFECTIOUS DISEASES, 1998, 27 (05) :1247-1254

[5]

The Mayo Prosthetic Joint Infection Risk Score: Implication for Surgical Site Infection Reporting and Risk Stratification [J].

Berbari, Elie F. ;

Osmon, Douglas R. ;

Lahr, Brian ;

Eckel-Passow, Jeanette E. ;

Tsaras, Geoffrey ;

Hanssen, Arlen D. ;

Mabry, Tad ;

Steckelberg, James ;

Thompson, Rodney .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2012, 33 (08) :774-781

[6]

Understanding the Determinants of Antimicrobial Prescribing Within Hospitals: The Role of "Prescribing Etiquette" [J].

Charani, E. ;

Castro-Sanchez, E. ;

Sevdalis, N. ;

Kyratsis, Y. ;

Drumright, L. ;

Shah, N. ;

Holmes, A. .

CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) :188-196

[7]

BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults [J].

Coakley, G. ;

Mathews, C. ;

Field, M. ;

Jones, A. ;

Kingsley, G. ;

Walker, D. ;

Phillips, M. ;

Bradish, C. ;

McLachlan, A. ;

Mohammed, R. ;

Weston, V. .

RHEUMATOLOGY, 2006, 45 (08) :1039-1041

[8]

Diaz-Ledezma C, 2014, J ARTHROPLASTY, V29, P1211, DOI [10.1016/j.arth.2013.09.039, 10.1016/j.arth.2013.12.020]

[9]

ORAL RIFAMPIN PLUS OFLOXACIN FOR TREATMENT OF STAPHYLOCOCCUS-INFECTED ORTHOPEDIC IMPLANTS [J].

DRANCOURT, M ;

STEIN, A ;

ARGENSON, JN ;

ZANNIER, A ;

CURVALE, G ;

RAOULT, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (06) :1214-1218

[10]

Three-decade trends in the distribution of organisms causing septic arthritis in native joints: Single-center study of 374 cases [J].

Dubost, Jean-Jacques ;

Couderc, Marion ;

Tatar, Zuzana ;

Tournadre, Anne ;

Lopez, Julien ;

Mathieu, Sylvain ;

Soubrier, Martin .

JOINT BONE SPINE, 2014, 81 (05) :438-440

← 1 2 3 4 5 6 7 →